Literature DB >> 15297046

Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data.

M A J B Tacken1, J C C Braspenning, A Berende, E Hak, D H De Bakker, P P Groenewegen, R P T M Grol.   

Abstract

A general practice (GP) based retrospective cohort study was conducted to assess the effects of influenza vaccination on the primary care contact rate during influenza epidemics. Given the rising workload of family physicians, particularly due to ageing of the population, it is very relevant to know to whether influenza vaccination of high-risk patients reduces the contact rate during epidemics. No effect of vaccination was found on the contact rate of GP during a mild epidemic period. During a 'normal' influenza epidemic, the workload was reduced through fewer contacts by patients with cardiovascular or diabetic diseases. Epidemic periods severe enough to show contact rate reduction occurred approximately every other year.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15297046     DOI: 10.1016/j.vaccine.2004.02.017

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Internet-based monitoring of influenza-like illness (ILI) in the general population of the Netherlands during the 2003-2004 influenza season.

Authors:  Richard L Marquet; Aad I M Bartelds; Sander P van Noort; Carl E Koppeschaar; John Paget; François G Schellevis; Jouke van der Zee
Journal:  BMC Public Health       Date:  2006-10-04       Impact factor: 3.295

2.  Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review.

Authors:  Gael Dos Santos; Halima Tahrat; Rafik Bekkat-Berkani
Journal:  Hum Vaccin Immunother       Date:  2018-04-09       Impact factor: 3.452

3.  Prescription of antiviral drugs during the 2009 influenza pandemic: an observational study using electronic medical files of general practitioners in the Netherlands.

Authors:  Mariëtte Hooiveld; Tine van de Groep; Theo J M Verheij; Marianne A B van der Sande; Robert A Verheij; Margot A J B Tacken; Gerrit A van Essen
Journal:  BMC Pharmacol Toxicol       Date:  2013-10-21       Impact factor: 2.483

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.